Supilanas, Noregen B.
HRN: 15-63-12 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/18/2026
CEFUROXIME 500MG (TAB)
07/18/2026
07/24/2026
PO
500mg
BID
UTI Following Delivery
Checking Final Appropriateness
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes